Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

H. Lee Moffitt Cancer Center and Research Institute · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
multiple-myeloma
multiple myeloma, autologous hematopoietic cell transplantation (hct), high-dose melphalan, selinexor, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 880624
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.